Home Tags Immunoinformatics

Tag: Immunoinformatics

EPIVAX AND CUBRC have been awarded a two-year, $1 million federal contract from the U.S. Food and Drug Administration to establish best practices and procedures for assessing generic peptides and related impurities for immunogenic potential. EpiVax CEO and Chief Science Officer Dr. Anne S. De Groot said generic peptides drugs are a quickly growing market. / PBN FILE PHOTO/MICHAEL SALERNO

EpiVax and CUBRC win $1M FDA contract to establish best practices...

PROVIDENCE – EpiVax Inc. and CUBRC Inc. have been awarded a two-year, $1 million federal contract from the U.S. Food and Drug Administration to...
FAST SEQUENCING: Dr. Anne S. De Groot, EpiVax Inc. CEO and chief strategy officer, says the Providence company has spent the past 20 years developing immunoinformatics tools. EpiVax spinoff EpiVax Oncology will use those tools along with fast sequencing to design cancer vaccines specific to individual patients. / PBN PHOTO/MICHAEL SALERNO

Renowned vaccine researcher Dr. Anne S. De Groot is ready to...

In 1997, Dr. Anne S. De Groot founded EpiVax Inc. in ­Providence, backed by a Small Business Innovation Research grant from the National Institutes...
- Featured Event -

Latest News